151 related articles for article (PubMed ID: 23263160)
21. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
Lehne G; Rugstad HE
Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
[TBL] [Abstract][Full Text] [Related]
22. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells.
Wang H; Giuliano AE; Cabot MC
Mol Cancer Ther; 2002 Jul; 1(9):719-26. PubMed ID: 12479368
[TBL] [Abstract][Full Text] [Related]
23. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
Cabot MC; Han TY; Giuliano AE
FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.
Govindarajah N; Clifford R; Bowden D; Sutton PA; Parsons JL; Vimalachandran D
Crit Rev Oncol Hematol; 2019 Jun; 138():104-111. PubMed ID: 31092365
[TBL] [Abstract][Full Text] [Related]
25. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
[TBL] [Abstract][Full Text] [Related]
26. Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin.
Lai M; Amato R; La Rocca V; Bilgin M; Freer G; Spezia P; Quaranta P; Piomelli D; Pistello M
Sci Rep; 2021 May; 11(1):11221. PubMed ID: 34045496
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells.
Kao LP; Morad SAF; Davis TS; MacDougall MR; Kassai M; Abdelmageed N; Fox TE; Kester M; Loughran TP; Abad JL; Fabrias G; Tan SF; Feith DJ; Claxton DF; Spiegel S; Fisher-Wellman KH; Cabot MC
J Lipid Res; 2019 Sep; 60(9):1590-1602. PubMed ID: 31363040
[TBL] [Abstract][Full Text] [Related]
28. Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (ΛΨm).
Du Y; Zhang J; Tao Z; Wang C; Yan S; Zhang X; Huang M
J BUON; 2019; 24(2):746-753. PubMed ID: 31128032
[TBL] [Abstract][Full Text] [Related]
29. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity.
Realini N; Solorzano C; Pagliuca C; Pizzirani D; Armirotti A; Luciani R; Costi MP; Bandiera T; Piomelli D
Sci Rep; 2013; 3():1035. PubMed ID: 23301156
[TBL] [Abstract][Full Text] [Related]
30. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
[TBL] [Abstract][Full Text] [Related]
31. N-Metallocenoylsphingosines as targeted ceramidase inhibitors: Syntheses and antitumoral effects.
Rothemund M; Bär A; Klatt F; Weidler S; Köhler L; Unverzagt C; Kuhn CD; Schobert R
Bioorg Chem; 2020 Apr; 97():103703. PubMed ID: 32143017
[TBL] [Abstract][Full Text] [Related]
32. Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
Morad SA; Levin JC; Shanmugavelandy SS; Kester M; Fabrias G; Bedia C; Cabot MC
Mol Cancer Ther; 2012 Nov; 11(11):2352-61. PubMed ID: 22962326
[TBL] [Abstract][Full Text] [Related]
33. The apoptotic and autophagic properties of two natural occurring prodrugs, hyperoside and hypoxoside, against pancreatic cancer cell lines.
Boukes GJ; van de Venter M
Biomed Pharmacother; 2016 Oct; 83():617-626. PubMed ID: 27459118
[TBL] [Abstract][Full Text] [Related]
34. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
Cabot MC; Giuliano AE; Han TY; Liu YY
Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
[TBL] [Abstract][Full Text] [Related]
35. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
36. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
37. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
Gardner AI; Haq IJ; Simpson AJ; Becker KA; Gallagher J; Saint-Criq V; Verdon B; Mavin E; Trigg A; Gray MA; Koulman A; McDonnell MJ; Fisher AJ; Kramer EL; Clancy JP; Ward C; Schuchman EH; Gulbins E; Brodlie M
Am J Respir Crit Care Med; 2020 Oct; 202(8):1133-1145. PubMed ID: 32569477
[No Abstract] [Full Text] [Related]
39. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside.
Newman RA; Kondo Y; Yokoyama T; Dixon S; Cartwright C; Chan D; Johansen M; Yang P
Integr Cancer Ther; 2007 Dec; 6(4):354-64. PubMed ID: 18048883
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells.
Ortega JA; Arencibia JM; La Sala G; Borgogno M; Bauer I; Bono L; Braccia C; Armirotti A; Girotto S; Ganesan A; De Vivo M
J Med Chem; 2017 Jul; 60(13):5800-5815. PubMed ID: 28603987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
